Actinium Pharmaceuticals, Inc. · 6 hours ago
Vice President of Business Development
NYC Metro Area
Full-time
Onsite
Director/Executive
10+ years expActinium Pharmaceuticals, Inc. is a leader in the rapidly growing field of radiopharmaceuticals. The Vice President of Business Development will lead the company's partnering and transaction strategy, working directly with the CEO and executive team to drive business growth through licensing, collaborations, and strategic transactions.
BiotechnologyClinical TrialsHealth DiagnosticsPharmaceutical
Responsibilities
Partner with the CEO and Executive Team to define and execute Actinium’s business development strategy, with a strong emphasis on out-licensing
Identify, evaluate, and pursue partnering opportunities aligned with scientific, clinical, and corporate objectives
Lead deal execution: business cases, valuation and financial modeling, scenario planning, diligence, structuring, negotiation, and contract execution
Serve as Actinium’s primary BD representative at partnering conferences, scientific meetings, and industry events
Own competitive intelligence and market landscape analysis; keep senior leadership informed of key developments
Lead cross-functional diligence teams (research, clinical, CMC, commercial, legal)
Prepare and present strategic recommendations to senior management and the Board
Collaborate closely with Research and Clinical teams to shape externally facing partnering narratives
Provide BD input to internal programs, identifying gaps and partnership-based solutions
Qualification
Required
10+ years of progressive experience in biotech/pharma business development
Bachelor's degree required; MBA and/or advanced scientific degree strongly preferred
Proven track record of sourcing, structuring, negotiating, and closing in- and out-licensing deals
Strong command of asset valuation, financial modeling, and ROI analysis
Deep understanding of drug development, preferably in oncology
Credibility with senior executives and a strong industry network
Ability to translate complex science into compelling strategic narratives
Comfortable operating autonomously while partnering closely with senior leadership
Benefits
Competitive compensation including base, bonus, equity, 401(k) match, and comprehensive benefits
Company
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers.
11-50 employees
Funding
Current Stage
Early StageTotal Funding
unknownKey Investors
National Institutes of Health
2023-10-04Grant
Leadership Team
Steve O' Loughlin
Chief Financial Officer
Recent News
2025-12-13
2025-12-12
2025-12-01
Company data provided by crunchbase